Results 291 to 300 of about 41,042,307 (363)
Mitochondrial dynamics and T cells immunity in cancer. [PDF]
Li X +5 more
europepmc +1 more source
Transcriptional and phenotypic alterations of regulatory and effector T cells in type 1 diabetes mellitus. [PDF]
Li Y, Zhao X, Xie M, Elkord E.
europepmc +1 more source
Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells. [PDF]
Basu V +8 more
europepmc +1 more source
Vγ9Vδ2 T cells in tuberculosis: protective immunity and translational perspectives. [PDF]
Shi Z +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pan-cancer single-cell landscape of tumor-infiltrating T cells
Science, 2021Description An atlas of cancer-associated T cells The tumor microenvironment contains many different kinds of immune cells, the composition, function, and roles of which are unclear.
Liang-Tao Zheng +18 more
semanticscholar +1 more source
T-cell therapies for T-cell lymphoma
Cytotherapy, 2019T-cell lymphomas represent a subpopulation of non-Hodgkin lymphomas with poor outcomes when treated with conventional chemotherapy. A variety of novel agents have been introduced as new treatment strategies either as first-line treatment or in conjunction with chemotherapy. Immunotherapy has been demonstrated to be a promising area for new therapeutics,
Keri Toner +2 more
openaire +2 more sources
2020
In 1891, Dr. William B. Coley, an American surgeon, made a compelling observation that immune system can be triggered to shrink tumors. The quest to exploit the power of immunotherapy however was forestalled by an era of chemotherapy that ensued.
Ranjit, Nair, Jason, Westin
openaire +3 more sources
In 1891, Dr. William B. Coley, an American surgeon, made a compelling observation that immune system can be triggered to shrink tumors. The quest to exploit the power of immunotherapy however was forestalled by an era of chemotherapy that ensued.
Ranjit, Nair, Jason, Westin
openaire +3 more sources

